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Abstract
Introduction The failure to follow-up pathology and
medical imaging test results poses patient-safety risks
which threaten the effectiveness, quality and safety of
patient care. The objective of this project is to: (1) improve
the effectiveness and safety of test-result management
through the establishment of clear governance processes
of communication, responsibility and accountability;
(2) harness health information technology (IT) to inform
and monitor test-result management; (3) enhance the
contribution of consumers to the establishment of safe and
effective test-result management systems.
Methods and analysis This convergent mixedmethods project triangulates three multistage studies
at seven adult hospitals and one paediatric hospital in
Australia. Study 1 adopts qualitative research approaches
including semistructured interviews, focus groups and
ethnographic observations to gain a better understanding
of test-result communication and management practices
in hospitals, and to identify patient-safety risks which
require quality-improvement interventions. Study 2
analyses linked sets of routinely collected healthcare
data to examine critical test-result thresholds and
test-result notification processes. A controlled beforeand-after study across three emergency departments
will measure the impact of interventions (including
the use of IT) developed to improve the safety and
quality of test-result communication and management
processes. Study 3 adopts a consumer-driven approach,
including semistructured interviews, and the convening
of consumer-reference groups and community forums.
The qualitative data will identify mechanisms to enhance
the role of consumers in test-management governance
processes, and inform the direction of the research and
the interpretation of findings.
Ethics and dissemination Ethical approval has been
granted by the South Eastern Sydney Local Health District
Human Research Ethics Committee and Macquarie
University. Findings will be disseminated in academic,
industry and consumer journals, newsletters and
conferences.

Strengths and limitations of this study
►► The description of multiple processes used to

manage test results across seven adult hospitals
and a children’s hospital will provide rich and unique
comparative evidence about hospitals of different
size, geographical location (rural, regional and
metropolitan) and specialty.
►► We will use an innovative data-driven approach
to generate evidence about the impact of critical
results notification thresholds on test-result followup processes and outcomes across different patient
groups.
►► We will ensure consumer engagement across all
stages of the study from inception to dissemination,
and capture experiences and opinions of a range
of health consumer representatives and front-line
patients.
►► Our quantitative analysis is limited to data related
to patients admitted to hospital. We will be able to
monitor readmissions across participating hospital
sites. There are some consequences of failure to
follow-up test results (eg, mortality after discharge
or readmission to hospitals not involved in the study)
that we will not be able to measure.
►► Qualitative evaluation methods are often conducted
with smaller samples which means that findings may
not be readily generalisable to larger populations.
Nevertheless, qualitative research findings will
provide context-rich insights that can expand the
scientific knowledge base. Our mixed-methods
approach allows for triangulation and draws on the
strengths of qualitative and quantitative approaches.

Introduction
WHO, World Alliance for Patient Safety has
identified poor test-result management as a
high-priority patient-safety area.1 Systematic
reviews in test-result follow-up have shown
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The establishment of effective test-result management
systems in hospitals
Tackling the issue of test-result follow-up goes hand-inhand with the establishment of an integrated governance
structure ensuring the safety of patient care. Effective clinical governance systems involve the clear delineation of
responsibilities, communication and workforce accountability, along with systems to monitor progress and deal
with any risks or impediments.9 Many clinicians describe
existing test-result management systems as inefficient and
chaotic.10 There is a lack of clarity about responsibilities
and accountabilities of ordering versus treating clinicians
for test-result follow-up, especially in relation to attending
to time-critical results.8 11
Clear guidelines and standards for test-result follow-up
Pathology and medical imaging services perform a major
role in the delivery of patient care by ensuring reliable and
accurate results are delivered in a timely fashion to inform
clinical management decisions.1 One of the main sources
of problems is errors in the reporting phase of the laboratory process, when test-result information is communicated to the requesting (or referring) clinician. Such errors
are often due to a lack of agreed standards or guidelines
among laboratories, medical imaging departments, hospitals and other healthcare settings about what are critical,
unexpected or significantly abnormal results, and when and
2

how these results should be communicated to the responsible clinician.12 13 Definitions of thresholds for critical tests
and subsequent notification processes for critical pathology
and imaging test results are largely based on consensus and
expert opinions, and lack a rigorous evidence base.12 Good
practice recommendations in this area emphasise the importance of clear definitions of key terms, the need for agreed
alert thresholds and time frames, and specified procedures
for fail-safe communication of test results that pose a critical or significant risk to patient safety.8 12 13 This lack of standards is currently under review by a collaboration between
the Royal College of Pathologists of Australasia (RCPA) and
the Australian Association of Clinical Biochemists (AACB)
which has established the Pathology Information, Terminology and Units Standardisation programme.14 This new
initiative aims to draw on existing evidence from pathology
datasets to establish standardised pathology information
structures and terminologies to improve recording, decision
support and communication of laboratory information.
Harnessing IT
Several electronic applications have been developed to
support test-result management processes. These include
systems that can track pending test results at hospital
discharge,15 deliver result alerts to clinicians, act as
safety nets in result notification16 or use tracking systems
to document acknowledgement and clinical actions.6
Intuitively, one would have expected the development
of electronic systems to overcome problems associated
with the existence of hospital data silos, yet poor integration of electronic systems has emerged as one of the
most significant hazards to patient safety in Australia and
internationally.17 At any one point in time, most hospitals are unable to identify critical test results which have
not been reviewed unless they conduct time-consuming
and cumbersome audits involving paper (and electronic)
records.18 In such cases, the identification of missed test
results may well be too late to have any positive effect on
patient safety.2 However, performing sophisticated data
linkage provides opportunities for leveraging the vast
quantities of information held in these existing datasets
to support the monitoring of test-result follow-up, derive
new evidence to establish clinically meaningful critical
test-result thresholds and to identify the consequences of
test-result notification practices.16 Sophisticated models
developed for linking previously fragmented hospital
databases within and across multiple hospitals have been
used to successfully monitor key indicators of hospital
performance, including test-ordering patterns, test-result turnaround times and to investigate the relationships
between testing patterns and patient outcome measures
such as patient length of stay and mortality.19
Enhancing the contribution of consumers in the testmanagement process
Failure to inform patients of their test results can have
devastating consequences for their health4 and has been
described as legally indefensible in malpractice claims.20
Dahm MR, et al. BMJ Open 2018;8:e020235. doi:10.1136/bmjopen-2017-020235
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that pathology and imaging test results fail to be followed
up for 20%–62% of inpatients, and for up to 75% of
patients treated in an emergency department (ED).2
Other research from a Sydney hospital showed that tests
ordered on the day of patient discharge accounted for
47% of missed test results, raising questions about the
necessity and appropriateness of ordering tests whose
results are most likely never reviewed.3 Poor test-result
follow-up can have major consequences for quality of
care, including missed diagnoses and suboptimal patient
outcomes.4 The urgency of the problem was highlighted
by the US Emergency Care Research Institute’s 2017
report on patient-safety concerns for healthcare organisations. The report listed data-integrity failures associated
with health information systems, poor care coordination
across levels of care and test-result reporting problems
among their top 10 patient-safety concerns for 2017.5
Information technology (IT) has a key role to play in the
communication and follow-up of test results.6 However,
new models of test management supported by IT can
only succeed if they are part of robust clinical governance
processes which can underpin safe test management.7
Effective solutions must engage all stakeholders to arrive
at decisions about who needs to receive the test results,
how and when the results are communicated, and how
they are acknowledged and acted on.8 Meeting these challenges requires the establishment of robust and resilient
partnerships between managers, clinicians, pathology
and medical imaging departments, and must include the
involvement of consumers.
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SES LHD and SCHN

ED presentations 2016* ICU

IS LHD

ED presentations 2016* ICU

Prince of Wales Hospital

54 443

✓

Shellharbour Hospital

29 479

–

Royal Hospital for Women, Sydney

Not applicable

✓†

Shoalhaven Hospital

38 039

✓

St George Hospital

76 228

✓

Wollongong Hospital

61 348

✓

Sutherland Hospital

50 025

✓

Sydney Children’s Hospital
Total

36 700
217 396

✓
128 899

*Calculated using quarterly data of presentations to EDs (January–December 2016) via Bureau of Health Information interactive data portal
Healthcare Observer.47
†Acute care service.
ED, emergency department; ICU, intensive care unit; IS, Illawarra Shoalhaven; LHD, Local Health District; SCHN, Sydney Children’s Hospital
Network; SES, South Eastern Sydney.

Effective partnerships between patients and clinicians,
and increased consumer engagement, have the reported
benefits of making healthcare safer and better.21 22 This is
relevant to test-result follow-up where patients can access
their own appointment and personal information, and
facilitate communication with health professionals by
using secure electronic patient portals to access their electronic health records.23 However, major obstacles hinder
the involvement of consumers, including a lack of educational tools and self-management guides outlining when
it may be necessary to seek medical assistance.22 There is
no consensus among clinicians regarding if, and when,
patients should have access to their test results.24 Many
clinicians report the need for consumer education and
support tools if strategies such as the direct notification of
results to consumers are instituted.25 This is contrasted by
the views of many consumers who report they want access
to their test results.26 It is crucial that consumers are
involved in informing the development of any such strategies and advise on the type of tools which may be most
effective and acceptable to a wide spectrum of consumers.
This National Health and Medical Research Council
(NHMRC)-funded Partnership Project, undertaken in
collaboration with the New South Wales (NSW) Health
Pathology and the Australian Commission on Safety and
Quality in Health Care (The Commission), will run from
2016 to 2020 and aims to make a significant contribution
to enhanced patient safety in Australia and internationally.
This innovative and comprehensive mixed-methods project
combines quantitative and qualitative research across three
studies to assess if the introduction of health IT incorporating clearly defined standards of communication, responsibility and accountability among pathology and medical
imaging departments, hospital management and clinicians,
and underpinned by consumer engagement will lead to
improved safety and effectiveness of test-result follow-up
practices.
The project’s three aims will be addressed in three
studies:
Aim 1: to improve the effectiveness and safety of test-result management through the establishment of clear
Dahm MR, et al. BMJ Open 2018;8:e020235. doi:10.1136/bmjopen-2017-020235

processes of communication, responsibility and accountability (study 1);
Aim 2: to harness health IT to inform and monitor
test-result management (study 2);
Aim 3: to enhance the contribution of consumers to
the establishment of safe and effective test-result management systems (study 3).

Methods
Project design and setting
We will conduct a convergent mixed-methods27 project
over a 5-year period concurrently collecting qualitative
and quantitative data for triangulation and corroboration. Integrating complementary qualitative and quantitative approaches will allow us to develop a more complete
understanding of the complex issues surrounding test-result management and contribute to the evidence base to
inform the development of interventions to enhance the
safety and quality of test-result management.
The project will involve the Emergency Departments
(EDs), intensive care units (ICUs) and general admission
wards at eight hospitals in the Sydney Children’s Hospital
Network, South Eastern Sydney (SES) and Illawarra
Shoalhaven (IS) Local Health Districts (LHDs) in NSW,
Australia. In 2016, the study hospitals provided care to
more than 340 000 ED presentations. Table 1 provides an
overview of all hospital sites for this project, the number
of presentations to each ED in 2016 and provision of ICU
services.
Research plan
Study 1
Aim: Improve the effectiveness and safety of test-result
management through the establishment of clear processes
of communication, responsibility and accountability.
We will adopt a problem-focused approach28 to map
current test-management practices within our study sites,
to develop an organisational test-result management clinical governance checklist and to implement improved
test-management governance processes.
3
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Table 1 ED presentations for 2016 and provision of ICU services across study hospital sites in SES LHD and IS LHD
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To map test-management practices to outline current
levels of communication, responsibility and accountability,
the research team will use a range of qualitative appraisal
techniques including audio-recorded focus groups, interviews with up to 10 clinical staff, and ‘Think-Aloud’ work
observations with up to four clinical staff within each of
the EDs, ICUs, general admission wards, pathology laboratories and medical imaging departments of the hospital
study sites. Directors and nurse unit managers of the relevant departments at the study hospitals will be provided
with introductory recruitment letters, along with participant information sheets and consent forms to be distributed to potential participants.
Depending on the hospital size, two members of the
research team will be present at each site for a duration
of 2–5 days, when clinical staff will be invited to participate in interviews. Interviews are expected to last between
20 and 30 min, focus groups up to 40 min. We anticipate that up to 50 interviews at each hospital site will be
conducted for this part of the study (ie, ~10 staff for each
department) to capture all levels of staff across managerial and clinical hierarchies.
4

Questions for the semistructured interviews and focus
groups will be exploratory, and are informed by current literature. They will cover aspects of test ordering, result notification and acknowledgement, delineation of abnormal versus
critical versus significant results and communication of test
results to patients, and within and across wards, and hospitals.8 28 29 Multimodal data will be collected in the form of
observational field notes, audio recordings, photographs and
other relevant artefacts. All audio recordings will be de-identified and transcribed. We will employ triangulation of data,
undertake participant validation via member checking and
involve multiple researchers in qualitative coding to ensure
the trustworthiness of the qualitative data.30 Transcripts will
be analysed inductively for emerging themes31–33 by at least
two members of the research team and analysed iteratively
using NVivo qualitative data analysis software (QSR International, V.11, 2015). Qualitative data will be used to identify,
map and compare current test-management work processes
(eg, documenting the communication channels used for
alerting doctors to critical test results) in the laboratories
and different clinical environments across hospitals.33
Differences in test-management practices between
hospitals will be identified, and adherence to national and
Dahm MR, et al. BMJ Open 2018;8:e020235. doi:10.1136/bmjopen-2017-020235
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Figure 1 Data extraction and linkage outline. DRG, Diagnosis-related group; ED, emergency department; ICD, International
Statistical Classification of Diseases and Related Health Problems; SNOMED, Systematized Nomenclature of Medicine.
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Acknowledgement rate
Before
Percentage change

45.0%
+20.0%

After

54.0%

Number of critical tests to be reviewed per study
period for each arm at each site (n)

700

Number of critical tests to be reviewed at each
site (2n)
Number of critical tests to be reviewed at three
ED sites during the study period

1400
4200

ED, emergency department.

international recommendations and guidelines (where
they exist) will be assessed to pinpoint evidence-practice
gaps. These investigations will identify communication
practices regarding:
►► how test results of different levels of importance
(eg, urgent, life threatening, critical but non-urgent results, etc) are communicated to clinicians in
different settings (eg, ED vs ICUs);
►► how responsibility is managed (eg, identification of
who is sent the test result, escalation procedures when
a responsible medical officer is unavailable);
►► accountability structures (eg, organisational level
procedures to identify test results which have not
been reviewed across defined periods).
A test-result management clinical governance checklist
will draw on empirical evidence and will be developed
through an iterative consultation process with our stakeholders. Based on the findings of study 1, we will draft
a proposal checklist to be shared for comments (eg,
to identify specific areas for intervention) with clinicians, laboratory and management staff at the hospitals
during a series of workshops and with consumers in
our community forum (see the Study 3 section). Stakeholder feedback will contribute to revisions of the checklist and stakeholders will be engaged in the approval of
the checklist. The aim of the checklist will be to provide
clear guidance to hospitals regarding the standardisation
of test-management practices which will reduce the risk
of failure to follow-up test results. Individual organisations will be able to compare existing processes against
the checklist to identify areas requiring revision and/or
change. The checklist is a change facilitation artefact that
will serve a dual role—first, as a purpose-designed framework to direct the conduct of actions by the healthcare
organisations,9 34 and second, as a translational research
product which will be iteratively refined and developed
for application in other healthcare settings (eg, general
practice) across Australia and internationally.
Following on from the workshops, our research partners in NSW Health Pathology and across the participating hospitals will use the checklist to identify and
deploy interventions aimed at improving the effectiveness
Dahm MR, et al. BMJ Open 2018;8:e020235. doi:10.1136/bmjopen-2017-020235

and safety of test-result management within each organisation. Interventions may include the introduction of
alert thresholds (relating to when a test result is considered urgent or critical) for a specified range of critical
laboratory test results (as identified by our partners).
Further intervention may involve implementation
changes related to recommended modes of communication
(eg, fax, pager, telephone or electronic alert) and clinical
governance processes (eg, escalation process in cases where
a doctor is not available).
Study 2
Aim: Harness health IT to inform and monitor test-result
management.
Study 2 employs a data-driven approach and advanced
data-linkage techniques using routinely collected data
from healthcare databases to inform and monitor test-result management. A retrospective longitudinal study will
be conducted to inform the adoption of critical test-result
thresholds and notification processes (eg, using an algorithm to identify acute kidney injury (AKI)). A controlled
before-and-after study across three EDs will be undertaken
to measure the impact of interventions on the safety and
quality of test results follow-up (eg, rates of result acknowledgement or rates of result return after discharge). Interventions include the clinical governance checklist developed
in study 1 and additional possible intervention(s) implemented independently by NSW Health Pathology during
the project period (eg, alert notification or clinical decision support systems).
Data linkage
Non-identifiable datasets from Laboratory Information
System (LIS), hospital patient administration system
(PAS), ED information system, ICU and Radiology Information System (RIS) will be provided to the research team
to create a dataset linking patient demographics, their
clinical information, test results and health outcomes.
Figure 1 provides examples of specific fields extracted
from each dataset, along with a schematic of the datalinkage process. Data will be rendered non-identifiable to
the research team by staff within NSW Health Pathology,
in such a way that a unique (quasi) patient ID will be
generated which will be used to link different datasets.
The research team will conduct a data quality assessment and analyse the data for accuracy, comparability,
completeness, conformity, consistency, relevance, timeliness, usability and validity.35 36 The initial dataset will
cover the period from 1 January 2010 to 30 December
2016. An annual data extract will then be made at the end
of June in each year of the study, to provide the research
team with all patient information from the previous year.
Retrospective longitudinal study
To aid our understanding of the relationships between critical test-result thresholds, subsequent notification procedures, and a range of key process and outcome indicators,
we will conduct a retrospective longitudinal study using
5
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acknowledgement rate for critical test result
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(from the LIS), 147 280 inpatient admissions (from PAS)
and 176 015 ED presentations (from the ED information
system, FirstNet).37 41 We anticipate a larger sample size
for this study as we will incorporate additional data from
ICUs andradiology information systems into the linked
dataset.
Controlled before-and-after study across three EDs
To measure the effects of a range of possible test-result
follow-up intervention(s) on care process and outcome indicators (to be decided in conjunction with our relevant stakeholders), we will conduct a controlled before-and-after study
across three EDs, with two ED sites receiving the same intervention(s) and one control ED site. The study will measure
the effects of interventions, eg, changes to critical test definitions, notification processes and changed modes of communication
(eg, fax, pager, telephone or electronic alert) and clinical
governance processes (eg, escalation process in cases where a
doctor is not available), on the treatment of patients and
their clinical outcomes. The study will concentrate on a set
of laboratory results (eg, sodium, potassium, lactate, creatinine, magnesium) where the results are either: (1) critical
and signify a pathophysiological state that is potentially life
threatening, or (2) may result in significant patient morbidity,
irreversible harm or mortality. The study will involve a retrospective clinical review of patient records carried out by two
trained clinical practitioners (eg, nurses) over 2 months in
years 3 and 5 of the project. The primary outcome measure
will be the number of critical results reported, acknowledged and
reviewed alongside the number where no acknowledgement
is recorded. The study will also consider secondary outcome
measures including: (1) the method by which these results
were communicated to and acknowledged by ED medical
practitioners, (2) the number of incidents of missed diagnosis and failure to act associated with unacknowledged
(likely missed) test results, (3) the treatment (and time to
treatment) associated with different critical test results, (4)
the impact on patient outcomes eg, death, length of stay,
discharge status (ie, transfer, admission to hospital or home)
or re-presentation within 28 days.
A systematic review showed that the lack of follow-up of
test results can reach up to 75% in EDs.2 Another study
reported an acknowledgement rate of 45% for test results
within critical values in EDs.42 Based on these data, we
estimate that to detect a 20% change in the acknowledgement rate we require a sample size of 700 critical test
results across each study period for each study site, and
another 700 tests during each (2 months) study period
for each control site, based on a two-sided test of proportions (alpha=0.05, power=0.9; table 2). Previous work
examining test follow-up in the ED has confirmed the
feasibility of this sample size.43
Study 3
Aim: Enhance the contribution of consumers to the
establishment of safe and effective test-result management systems.
Dahm MR, et al. BMJ Open 2018;8:e020235. doi:10.1136/bmjopen-2017-020235
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routinely collected healthcare data and apply robust multilevel models.37 Working in consortium teams with our clinical and scientific partners and focused on specific patient
groups (eg, patients undergoing tests such as potassium or
serum creatinine), we will identify patient cohorts whose
results fall within and outside existing definitions of critical
test results (drawing on the definitions identified in study
1). For example, we will conduct a retrospective examination of laboratory identification of AKI which is acquired by
approximately 13.3 million people globally, with mortality
expected in 10%–15% of affected individuals.38 A lack of
consensus around the definition of AKI has led to late identification and poor management of it leading to increased
mortality, with hospital patients likely to be discharged with
unrecognised AKI and others being managed inappropriately.39 40 A standardised AKI algorithm was produced in the
UK based on the serum creatinine changes described in the
Kidney Disease: Improving Global Outcomes classification.39
This was followed by an electronic patient-safety alert across
hospitals in England.39 We propose to undertake a retrospective cohort study of adult patients who were admitted
to participating hospital sites between January 2010 and
December 2013. The AKI cases will be identified by applying
the UK laboratory-based algorithm to the linked data from
laboratory and inpatient systems. The study will aim to: (1)
determine the incidence of AKI applying a laboratory-based
algorithm on the linked dataset, and (2) identify any AKI
cases that may have been missed by comparing the algorithm
findings to AKI status as recorded in the International Statistical Classification of Diseases and Related Health Problems,
Tenth Revision, Australian Modification (ICD-10-AM) codes.
This and additional retrospective studies will answer
questions such as whether different critical test thresholds
(and the consequent notification processes, eg, direct
phone call to a clinician vs passive alerting in the form of
an asterisked result) have any significant association with
a range of patient process or outcome indicators such
as length of stay, readmission or mortality. These findings will inform interventions projected by NSW Health
Pathology to be developed within the test-management
governance checklist framework in study 1, such as the introduction of new mobile or desktop technology to promote
the notification and acknowledgement of test results
or the development of context-specific frameworks for
identification and notification of results based on critical
risk, for example, abnormal, life-threatening and so on.
We will then investigate differences in a range of process
and outcome indicators for these patients, including time
taken for notification of pending/completed/verified
test results, time taken to access and acknowledge test
results, retest rates, time to ED disposition decision, ED
length of stay, mortality and readmission rates.
A previous project conducted in collaboration with
NSW Health Pathology across six hospitals in SES and IS
LHDs led to the development and extensive utilisation
of a dataset linking patient demographics, their clinical information, test results and outcomes. This linked
dataset incorporated some 2.8 million pathology tests

Open Access

Semistructured interviews with ED patients
To provide insights on test-result management processes
and gain an additional consumer viewpoint, we will
conduct semistructured interviews with adult patients
accessing services in EDs across the study sites. Clinicians will identify eligible patients in the ED who underwent a pathology or imaging test. These patients will be
approached and invited to participate in audio-recorded
semistructured interviews. Interviews will be designed
to cover their experiences regarding test-result management and result access during the current encounter,
and more generally, to gauge their views about access
to their personal health information in relation to test
results. This will involve identifying the needs of patients
to determine how pathology and medical imaging results
are presented, what information is needed to ensure
that results are easy to access and understand, and guide
patient-centred decision-making. Semistructured interviews with ~20 participants at each selected site are anticipated to last ~5 min and will be audio-recorded. Questions
will be informed by current literature and updated in line
with emerging findings from the other arms of the study.
Transcripts of recordings will be used for thematic analysis. It is envisioned that consumers will be engaged in
thematic analysis of these data. All qualitative data analysis in study 3 will be undertaken using the same software,
methods and measures for trustworthiness outlined for
study 1.
Consumer reference group
To enhance the contribution of consumers to safe test-result management, including the direct transmission of
test results to patients, we will establish a CRG which
engages health consumer representatives in the governance structure and all research phases of the project.
Dahm MR, et al. BMJ Open 2018;8:e020235. doi:10.1136/bmjopen-2017-020235

Trained health consumer representatives for the CRG
will be recruited via health consumer organisations (eg,
Health Consumers NSW and LHDs) and include other
key stakeholders (eg, Clinical Excellence Commission,
Royal College of Pathologists of Australasia (RCPA). The
CRG will provide feedback about the way that the study
findings impact on aspects of patient care to help shape
the direction of the research programme and inform the
design of informational and educational tools to advance
consumer engagement.
Community forums
To consider findings from the research and emerging issues
concerning the safety and quality of care as related to test-result management (eg, possible impact of innovations such as
the clinical governance checklist on work processes), members
of the CRG will also be invited to participate in community
forums to bring together 10 – 15 participants from major
community stakeholders (including consumer groups,
health professionals, IT vendors and healthcare organisations). A minimum of two forums will be held until project
completion, and participants will be invited to discuss the
research findings and help shape their translational capacity
and diffusion across the healthcare community. Health
consumer representatives will be reimbursed for their time
at a rate of $AUD40 (as per nominated reimbursement
rates)45 for each CRG meeting they attend. At CRG meetings, data will be collected in the form of observational field
notes and audio recordings, and transcripts of recordings
will be used for thematic analysis. This information will be
used to include the consumer perspective in the interpretation of findings and identify direction for further research.

Expected outcomes and significance
The translation of the findings from this study will help
organisations address key issues related to the management and accountability of test-result management
systems across all organisational levels. Our research
engagement with our collaborating partners will generate
evidence about the safety and effectiveness of major
test-result follow-up interventions across laboratories,
medical imaging departments and hospitals. The study
will contribute to: (1) improved hospital care and health
service delivery, (2) the development of healthcare guidelines to improve the delivery of safe and quality care,
(3) improved end-user accessibility and involvement in
health services and (4) increased health system capacity.
Study 1 will adopt a qualitative approach to map the
test-result management and notification processes across
eight study sites. This study will describe the multiple
processes used to manage test results across seven adult
hospitals and a children’s hospital. Study 1 will produce
a test-result management clinical governance checklist which
represents a substantial contribution to the establishment
of resilient governance structures that promote accountability in how test results are managed within and across
healthcare settings. The checklist will help healthcare
7
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This study adopts the philosophy of doing with rather than
doing for, and is aimed at ensuring consumer involvement in
all stages of the project from inception to dissemination. We
sought advice from consumer representative organisations
during the development of the research grant proposal
(2014–2015). This collaboration focused on the role of
patients in improving test-result management systems, and
showed that the level of patient involvement in their care
may be influenced by a number of factors, including health
literacy levels, and access to appropriate tools, and educational and decision support aids.44
We will adopt three approaches to increase the opportunity for contribution by consumers, including both
health consumer representatives and front-line patients,
across all aspects of the qualitative and quantitative studies
incorporated in this mixed-methods project, ranging from
governance to shaping the research direction, interpretation of findings and the development of revised test-management governance processes. To this end, we will (1)
conduct semistructured interviews with ED patients,
(2) establish consumer reference groups (CRGs) and
(3) conduct community forums.

Open Access

Ethics and dissemination
The release of non-identifiable unit record data for
research purposes has been approved by the Centre for
Epidemiology and Evidence, NSW Ministry of Health.
All participants in study 1 and study 3 will provide written
informed consent. These participants will not be asked for
their identity. Identifying information that could be coincidentally revealed during interviews/focus groups will be
de-identified during transcription or deleted from photographs and artefacts. The identity of participants will not be
disclosed in the reporting of the results.
The privacy and identities of individuals described in
the datasets used in study 2 will be protected by using
a non-identifiable dataset. Only results aggregated at
a high level will be reported. In the unlikely event of
a result that describes a small number of individuals,
statistical disclosure control methods (NSW Health,
Privacy Issues and the Reporting of Small Numbers,
September 2011) will be implemented to avoid the
inadvertent inferential disclosure of individual identities. These methods include collapsing cells, cell
suppression and cell modification, where appropriate.
All reported results will meet a conservative minimum
k>10 individuals threshold limit for ‘small cells’. While
the dataset could potentially be reidentified, the
8

coding used will be stored by NSW Health Pathology
and will not be revealed to the researchers.
The project is funded under an NHMRC Partnership
Project grant with local and national partners at clinical
and policy levels. Funding partners include NSW Health
Pathology, and the Australian Commission on Safety
and Quality in Health Care. Other stakeholders include
Health Consumers NSW, AACB, and RCPA. The study
team includes academic researchers, hospital and laboratory clinicians, and senior policy-makers from national
health and clinical agencies.
In the first instance, study findings will be reported at
executive level at the hospital sites and to partners in a
series of workshops to identify specific areas for intervention or to address any major safety or process issues
related to test-result management. In addition, findings will be disseminated to a diverse audience through
peer-reviewed academic literature, popular science
communications, industry and consumer newsletters and
journals, and at academic, industry and health consumer
conferences. Given the diversity of the project team,
further options for dissemination of results include translational and implementation strategies such as the inclusion of findings in the development of policy or health
information systems.
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organisations achieve the best possible patient outcomes
using governance systems that can track and monitor
results and ensure that they are acted on when needed.
Study 2 will take a highly innovative data-driven
approach to generate evidence regarding the relationships between critical test results (eg, results that
reach a threshold defined as ‘critical’) and notification practices (eg, the time between the issuing of a
critical result and when the clinician receives and/or
views the result), and a range of patient process and
outcome indications (eg, length of stay, mortality).
Such an approach has not been undertaken previously on such a large scale for a range of tests and
patient groups. The results of this aspect of the study
will provide evidence across multiple hospitals about
the effects of interventions on: (1) the number and
type of critical results that are received, acknowledged
and acted on; (2) the percentage of critical results
and their thresholds which lead to specific actions and
(3) the resultant impact on patient treatment and
outcomes.
Study 3 is founded on the active involvement of
consumers who will contribute to the design and
implementation of major interventions (including
eHealth applications) to enhance consumer engagement into the future.46 We will adopt multiple strategies to capture the experiences and opinions of trained
health consumer representatives and ED patients
covering all aspects and stages of the study from inception to dissemination, and from governance to interpretation of study findings.
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